Co-Diagnostics, Inc. (CODX) Operating cash flow 2016–2025
Co-Diagnostics, Inc. (CODX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.1MFY2025 · since FY2016: -$1.3M → -$29.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.1M | +0.1% |
| FY2024 | -$29.2M | -32.0% |
| FY2023 | -$22.1M | -436.2% |
| FY2022 | $6.6M | -84.0% |
| FY2021 | $41.1M | +45.9% |
| FY2020 | $28.2M | +609.8% |
| FY2019 | -$5.5M | -35.4% |
| FY2018 | -$4.1M | -27.0% |
| FY2017 | -$3.2M | -144.7% |
| FY2016 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice